19 completed, 2 terminated, 1 active not recruiting, 1 unknown. 23 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 23 | Completed 19, Terminated 2, Active not recruiting 1, Unknown 1 |
Follow solifenacin: new trials by email Literature Review of solifenacin trials Research Report on solifenacin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Tamsulosin and Solifenacin for Relieving Double J Stent Symptoms: Using the USSQ. Tamsulosin, solifenacin - Ureteral Stent-Related Symptom, Alpha Blocker | Phase 4 | Completed | Liaquat National Hospital & Medical College | 60 | 2024-06-13 | 2025-08-11 |
| Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry) Solifenacin, Mirabegron, Solifenacin + Mirabegron - Urinary Incontinence in Children | Phase 4 | Active not recruiting | University of Aarhus | 216 | 2024-05-27 | 2026-06-08 |
| Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder Anticholinergic, Beta-3 Agonists, Adrenergic, Functional magnetic resonance imaging (fMRI) - Overactive Bladder, Dementia | Phase 4 | Completed | Baylor Research Institute | 12 | 2019-08-05 | 2024-02-02 |
| Comparisons of the Effects of Solifenacin Versus Mirabegron on Autonomic System, Arterial Stiffness and Psychosomatic Distress and Clinical Outcomes solifenacin, mirabegron - Overactive Bladder Syndrome | Phase 4 | Completed | National Taiwan University Hospital | 113 | 2015-09-08 | 2023-03-28 |
| Comparison of Tamsulosin and Solifenacin in Treatment of Ureteral Stent Symptoms Tamsulosin, Solifenacin, Control - Relieve of Ureteral Stent Symptoms | Phase 4 | Completed | Mansoura University | 131 | 2013-01-01 | 2015-11-25 |
| A Study to Evaluate the Effect of Mirabegron + Solifenacin in Overactive Bladder Patients mirabegron, solifenacin - Overactive Bladder | Phase 4 | Completed | Astellas Pharma Inc | 223 | 2012-10-01 | 2018-02-28 |
| Incontinence & Intimate Partners: Assessing the Contribution of Treatment Solifenacin - Urge Urinary Incontinence | Phase 4 | Completed | Loyola University | 138 | 2012-03-09 | 2019-12-02 |
| Therapy of the Overactive Bladder Syndrome solifenacin, PFMT and WBVT - Overactive Bladder | Phase 4 | Completed | Cantonal Hospital, Frauenfeld | 66 | 2012-01-01 | 2016-05-20 |
| Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms Tamsulosin, Solifenacin - Lower Urinary Tract Symptoms | Phase 4 | Completed | Timothy Boone, MD, PhD | 10 | 2011-10-01 | 2018-04-02 |
| Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder Solifenacin, Oxybutynin - Overactive Bladder | Phase 4 | Unknown | Adana Numune Training and Research Hospital | 500 | 2011-09-01 | 2011-08-26 |
| A Study to Estimate the Efficacy and Safety of Solifenacin in Female With Stress Urinary Incontinence and Urgency Urinary Incontinence solifenacin - Stress Urinary Incontinence, Urgency Urinary Incontinence | Phase 4 | Completed | Jeong Gu Lee | 311 | 2011-06-01 | 2016-06-15 |
| The Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With Overactive Bladder (OAB) Solifenacin, Solifenacin plus Tamsulosin - Overactive Bladder | Phase 4 | Completed | Soonchunhyang University Hospital | 70 | 2010-12-01 | 2015-01-27 |
| A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin Treatment solifenacin - Over Active Bladder | Phase 4 | Completed | Astellas Pharma Inc | 100 | 2010-04-01 | 2014-07-10 |
| A Study to Compare Two Medications With an Inactive Medication and Look at the Effect on a Person's Mental Ability Solifenacin, Oxybutynin, Placebo - Cognition | Phase 4 | Completed | Astellas Pharma Inc | 26 | 2010-04-01 | 2012-10-15 |
| Clinical Trial of Solifenacin Versus Placebo Plus Pessary for Women With Vaginal Prolapse Solifenacin, Placebo, Ring pessary with support, Cooper Surgical, Trumbell, CT Ref # MXPRS03 non-latex - Pelvic Organ Prolapse | Phase 4 | Terminated | Hartford Hospital | 94 | 2010-03-01 | 2011-11-04 |
| Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder. Placebo, solifenacin - Detrusor Overactivity, Overactive Bladder | Phase 4 | Completed | Astellas Pharma Inc | 547 | 2010-01-19 | 2024-12-03 |
| Reproducibility Study of OABSS and Its Response to Treatment Solifenacin - Overactive Bladder | Phase 4 | Completed | Astellas Pharma Inc | 50 | 2009-09-01 | 2016-01-29 |
| Solifenacin Flexible Dosing Study in Frequent Micturition Patients With and Without Urgency Solifenacin - Urinary Bladder, Overactive, Overactive Bladder | Phase 4 | Completed | Asan Medical Center | 291 | 2009-04-01 | 2016-02-02 |
| A Study to Evaluate Add on Effect of Solifenacin in Men With Overactive Bladder Symptoms After Tamsulosin Monotherapy for 4 Weeks Solifenacin - Overactive Bladder | Phase 4 | Completed | KYU-SUNG LEE | 307 | 2009-03-01 | 2016-01-07 |
| Feasibility of "At-home" Titration of Solifenacin Solifenacin - Overactive Bladder | Phase 4 | Terminated | NYU Langone Health | 36 | 2008-09-01 | 2015-10-26 |
Showing 20 of 23. Sign in to see all of them.
Urinary Bladder, Overactive (13) · Lower Urinary Tract Symptoms (3) · Urinary Incontinence (2) · Urinary Incontinence, Urge (2) · Dementia (1) · Pelvic Organ Prolapse (1) · Prostatic Hyperplasia (1) · Urinary Incontinence, Stress (1) · Xerostomia (1)
Astellas Pharma Inc (6) · KYU-SUNG LEE (2) · Adana Numune Training and Research Hospital (1) · Asan Medical Center (1) · Astellas Pharma Taiwan, Inc. (1) · Baylor Research Institute (1) · Cantonal Hospital, Frauenfeld (1) · Hartford Hospital (1) · Jeong Gu Lee (1) · Liaquat National Hospital & Medical College (1) · Loyola University (1) · Mansoura University (1) · NYU Langone Health (1) · National Taiwan University Hospital (1) · Soonchunhyang University Hospital (1)
South Korea (6) · United States (5) · Canada (2) · Taiwan (2) · Turkey (Türkiye) (2) · United Kingdom (2) · Austria (1) · Belgium (1) · Bulgaria (1) · Czechia (1) · Denmark (1) · Egypt (1) · France (1) · Germany (1) · Hungary (1)
Ahmed R EL-Nahas, A. Professor (1) · Elizabeth Meuller, MD (1) · Jill Danford, MD (1) · Kwang Woo Lee, Ph.D (1) · Kyu-Sung Lee, MD (1) · Luise Borch, MD, PhD (1) · Murat Api, M.D., Ph.D. (1) · Myung-Soo Choo, Professor (1) · Paul Tulikangas, MD (1) · Rachel High, DO (1) · Rose Khavari, MD (1)
PMID 37160401, PMID 20690893, PMID 21175373, PMID 21789068, PMID 23332882, PMID 25363606, PMID 25401784, PMID 26453222, PMID 40633093
2008 (2)